% | $
Quotes you view appear here for quick access.

DepoMed Inc. Message Board

  • acricketeer acricketeer Apr 1, 2013 2:36 PM Flag

    Morning Ambush

    Rx Numbers for Gralise were flat but didn't warrant this kind of selloff. Perhaps an institution sold a chunk and leaned on the stock quickly. Roth Capital needs to update their reports to put Serada risk out of their equation. They give it zero value, but still give it an imputed FDA risk (even though funding has been discontinued).

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Acricketeer, the last Gralise Rx data posted here by Drive was for week ending 1/18/13 for 4086 total. Any new data you could offer would be greatly appreciated. TIA

    • I've researched this company, and I truly believe investors are confused. DEPO has no debt and a relatively good cash position. Granted, that while the new product pipeline is not stellar, the future for this organization appears to be fairly good with a current value of about $9 per share. Again, I believe investors are confused and perhaps the messaging has been poor or unclear from the organization itself.

      Sentiment: Strong Buy

19.25+0.55(+2.94%)Jul 28 4:00 PMEDT